Company Filing History:
Years Active: 2001-2014
Title: The Innovations of Peter Langballe
Introduction
Peter Langballe is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of growth hormones and insulin compositions. With a total of 2 patents, Langballe's work has had a meaningful impact on medical science.
Latest Patents
Langballe's latest patents include a pharmaceutical formulation that relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol. Additionally, he has developed stabilized insulin compositions, which are aqueous insulin compositions with improved chemical and physical stability. These compositions include human insulin or an analogue or derivative thereof, a buffer selected from glycylglycine, citrate, or TRIS, and metal ions, particularly calcium or magnesium ions.
Career Highlights
Throughout his career, Peter Langballe has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S and Novo Nordisk Healthcare AG. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
Langballe has collaborated with esteemed colleagues such as Elsebeth Norup and Søren Bjørn, contributing to various projects that enhance pharmaceutical innovations.
Conclusion
Peter Langballe's contributions to pharmaceutical formulations and his collaborations with leading professionals highlight his importance in the field of medical science. His patents reflect a commitment to improving the stability and efficacy of essential medications.